Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes

Cancer Research
Birgit HeltwegA Bedalov

Abstract

SIRT1 and other NAD-dependent deacetylases have been implicated in control of cellular responses to stress and in tumorigenesis through deacetylation of important regulatory proteins, including p53 and the BCL6 oncoprotein. Hereby, we describe the identification of a compound we named cambinol that inhibits NAD-dependent deacetylase activity of human SIRT1 and SIRT2. Consistent with the role of SIRT1 in promoting cell survival during stress, inhibition of SIRT1 activity with cambinol during genotoxic stress leads to hyperacetylation of key stress response proteins and promotes cell cycle arrest. Treatment of BCL6-expressing Burkitt lymphoma cells with cambinol as a single agent induced apoptosis, which was accompanied by hyperacetylation of BCL6 and p53. Because acetylation inactivates BCL6 and has the opposite effect on the function of p53 and other checkpoint pathways, the antitumor activity of cambinol in Burkitt lymphoma cells may be accomplished through a combined effect of BCL6 inactivation and checkpoint activation. Cambinol was well tolerated in mice and inhibited growth of Burkitt lymphoma xenografts. Inhibitors of NAD-dependent deacetylases may constitute novel anticancer agents.

References

Feb 1, 1987·The Journal of Cell Biology·G PipernoX J Chang
Feb 17, 2000·The EMBO Journal·M A Martínez-BalbásT Kouzarides
Jun 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·D E Sterner, S L Berger
Jun 30, 2000·Biochemical and Biophysical Research Communications·R A Frye
Dec 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·K G TannerJ M Denu
Mar 16, 2001·Current Opinion in Genetics & Development·S KhochbinD Seigneurin-Berny
Jun 28, 2001·Nature Structural Biology·M S FinninN P Pavletich
Jul 4, 2001·Nature Cell Biology·H M ChanN B La Thangue
Oct 24, 2001·Cell·H VaziriR A Weinberg
Oct 24, 2001·Current Opinion in Oncology·P A MarksR A Rifkind
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·A BedalovJ A Simon
May 25, 2002·Nature·Charlotte HubbertTso-Pang Yao
Oct 24, 2002·Blood·Margarita Sánchez-BeatoMiguel A Piris
Oct 29, 2002·Nature Genetics·Oksana R BereshchenkoRiccardo Dalla-Favera
Nov 1, 2002·Molecular Cell·Jose L AvalosCynthia Wolberger
Dec 17, 2002·Molecular and Cellular Biology·Michael W McBurneyMadeleine Lemieux
Dec 18, 2002·The EMBO Journal·Akihisa MatsuyamaMinoru Yoshida
Mar 7, 2003·Molecular Cell·Brian J NorthEric Verdin
May 3, 2003·Cancer Cell·Meredith S IrwinWilliam G Kaelin
Jul 12, 2003·Science·Diego H CastrillonRonald A DePinho
Jul 16, 2003·The Journal of Experimental Medicine·Huifeng NiuRiccardo Dalla-Favera
Jul 31, 2003·Molecular Cell·Marcella FulcoVittorio Sartorelli
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hwei-Ling ChengKatrin F Chua
Sep 16, 2003·Molecular and Cellular Biology·Antonio BedalovJulian A Simon
Oct 10, 2003·The Journal of Biological Chemistry·Maki HiraoAntonio Bedalov
Dec 10, 2003·Oncogene·Jonas A Nilsson, John L Cleveland
Mar 17, 2004·Molecular Cell·Haim Y CohenDavid A Sinclair
Apr 30, 2004·Journal of Medicinal Chemistry·Jeff PosakonyAntonio Bedalov
May 7, 2004·Genome Biology·Brian J North, Eric Verdin
Jun 4, 2004·Nature·Frédéric PicardLeonard Guarente
Jun 11, 2004·Annual Review of Biochemistry·Gil Blander, Leonard Guarente

❮ Previous
Next ❯

Citations

Dec 21, 2006·Archives of Dermatological Research·Yasutoshi HidaSeiji Arase
Dec 2, 2011·Systems and Synthetic Biology·Padavattan SivaramanBalasundaram Padmanabhan
Jan 24, 2012·Journal of the American Chemical Society·Bin HeHening Lin
May 6, 2009·Journal of the American Chemical Society·Tomomi AsabaNaoki Miyata
Aug 31, 2012·Journal of Medicinal Chemistry·Dante RotiliAntonello Mai
Apr 11, 2013·Journal of Medicinal Chemistry·Jeremy S DischRobert B Perni
May 8, 2009·Journal of Medicinal Chemistry·Federico MeddaNicholas J Westwood
Nov 24, 2012·Cell Death and Differentiation·P Y LiuT Liu
Feb 1, 2008·Nature·Wenhui ZhaoWei Gu
Mar 18, 2008·Nature Cell Biology·Timour ProzorovskiOrhan Aktas
Mar 10, 2011·Nature Medicine·Manuel Rodríguez-Paredes, Manel Esteller
Jan 10, 2009·Nature Reviews. Cancer·Christopher L Brooks, Wei Gu
May 25, 2007·Nature Reviews. Molecular Cell Biology·Armando van der Horst, Boudewijn M T Burgering
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Munekazu YamakuchiCharles J Lowenstein
May 5, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kimberly R HollowayKevin Pruitt
Dec 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Antje MenssenHeiko Hermeking
May 13, 2009·The Journal of Biological Chemistry·Neha KabraJiandong Chen
Dec 14, 2011·The Journal of Biological Chemistry·Min PanRonen Marmorstein
Dec 17, 2008·The Journal of Biological Chemistry·Brittney Jung-HynesNihal Ahmad
Nov 20, 2010·Journal of the National Cancer Institute·Joong Sup ShimJun O Liu
Aug 30, 2008·The American Journal of Surgical Pathology·Kyu Yun JangWoo Sung Moon
May 14, 2010·Cold Spring Harbor Perspectives in Biology·David P LaneSonia Lain
Jun 26, 2007·Science·Tiago Fleming OuteiroAleksey G Kazantsev
Sep 14, 2011·Journal of Biomedicine & Biotechnology·Ramkumar RajendranConstantinos Demonacos
Mar 5, 2013·The Journal of Clinical Investigation·Jessica A HallPere Puigserver
Oct 4, 2013·BMC Cancer·Albrecht StenzingerWilko Weichert
Jan 24, 2013·Molecular Endocrinology·Kimberly R HollowayKevin Pruitt
Sep 29, 2012·Current Pharmaceutical Design·Santina BruzzoneAlessio Nencioni
Dec 1, 2011·Epigenomics·Inge VerbruggeMichael Bots

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.